Validation of Time in Range as an Outcome Measure for Diabetes Clinical Trials

Beck, Roy W., Bergenstal, Richard M., Riddlesworth, Tonya D., Kollman, Craig, Li, Zhaomian, Brown, Adam S., Close, Kelly L.·2019·Diabetes Care
DOI 10.2337/dc18-1444

Cited by (792)

Items 501–600 of 792

  1. Impact of Continuous Glucose Monitoring and its Glucometrics in Clinical Practice in Spain and Future Perspectives: A Narrative Review
    Fernando Gómez Peralta, Isabel Leiva Gea, Natalia Duque, Esther Artime, Miriam Rubio‐de Santos · 2024 · Advances in Therapy
  2. Beyond HbA1c, second take
    Zachary T. Bloomgarden · 2019 · Journal of Diabetes
  3. Consensus Statement on Use of Ambulatory Glucose Profile in Patients with Type 2 Diabetes Mellitus Receiving Oral Antidiabetic Drugs.
    AG Unnikrishnan, Banshi Saboo, Shashank Joshi, Jothydev Kesavadev, B. M. Makkar, Sanjay Agarwal, S R Aravind, Krishna Seshadri, Manoj S Chawla, Neeta Deshpande et al. · 2019 · PubMed
  4. Metabolism of the hexose monophosphate shunt in glucose-6-phosphate dehydrogenase deficiency and closely interrelated reactions.
    Gisela Jacobasch, Renate Bleiber, G Schönian · 1982 · PubMed
  5. Glycemic control after switching to faster aspart in adults with type 1 diabetes
    Gian Paolo Fadini, Federico Boscari, Daniele Falaguasta, Sara Ferretto, Alberto Maran, Angelo Avogaro, Daniela Bruttomesso · 2022 · Journal of Endocrinological Investigation
  6. The Implication of Time-in-Range for the Management of Diabetes in India: A Narrative Review
    Sudhir Tripathi, Sushil Jindal, Manoj S Chawla, Arvind Gupta, Sujeet Kumar Jha, Uday Phadke, Tejal Bipin Lathia · 2022 · Clinical Diabetology
  7. Primary Care Providers' and Staff Confidence and Awareness of Continuous Glucose Monitors Following Pharmacist‐Led Education and Training: A Pre‐Post Cohort Study
    Amber N. Lilly, Cynthia A. King, Jasmin Ortiz · 2025 · JACCP JOURNAL OF THE AMERICAN COLLEGE OF CLINICAL PHARMACY
  8. Expanding the Use of Continuous Glucose Monitoring in Type 2 Diabetes Mellitus: Impact on Glycemic Control and Metabolic Health
    Mi Joon Lee, Bum-Jeun Seo, Jae‐Hyoung Cho · 2025 · Life
  9. Accuracy of continuous glucose monitoring in critically ill patients
    John D. Santamaria, Ebony Selers, David Reid · 2025 · Critical Care and Resuscitation
  10. Association between time in range and incident early diabetic kidney disease in patients with type 2 diabetes: a retrospective cohort study
    Ling Chen, Lingyan Zhang, Niuniu Zhou · 2026 · International Urology and Nephrology
  11. Correlación entre parámetros glucométricos de la monitorización continua flash y la hemoglobina glucosilada. Experiencia en vida real en Asturias
    Pedro Pujante, Carlos Alonso Felgueroso, Jessica Ares, Paula Morales-Sánchez, Carmen Lambert, Raúl Rodríguez Escobedo, Sandra Rodríguez‐Rodero, Elías Delgado, Edelmiro Luis Menéndez Torre · 2022 · Endocrinología Diabetes y Nutrición
  12. Can Faster Aspart Be Used to Optimize Glycemic Control With Insulin Pump Therapy? From Expectations to Lessons Learned After a Year of Use in the United States
    Grazia Aleppo, Bruce W. Bode, Anders L. Carlson · 2022 · Clinical Diabetes
  13. Whole Day Workload: Evaluation of a New Outcome Measure in Occupational Therapy for Adults With Type 1 Diabetes
    Raymond Hernandez, Stefan Schneider, Haomiao Jin, Claire J. Hoogendoorn, Pey-Jiuan Lee, Loree T. Pham, Elizabeth Ann Pyatak · 2024 · American Journal of Occupational Therapy
  14. Unveiling the Spectrum of Glucose Variability: A Novel Perspective on FreeStyle Libre Monitoring Data
    Adrian Hugh Heald, Mike Stedman, John Julian Warner-Levy, Lleyton Belston, Angela N. Paisley, Aleksandra Jotić, Nebojsa M. Lalic, Martin Gibson, Hellena Hailu Habte‐Asres, Martin Whyte et al. · 2024 · Diabetes Therapy
  15. The Application of Continuous Glucose Monitoring Endpoints in Clinical Research: Analysis of Trends and Review of Challenges
    Andrew M. Bevan, Graham Ellis, Mona Eskandarian, Davide Garrisi · 2024 · Journal of Diabetes Science and Technology
  16. Do continuous glucose monitoring (CGM) metrics predict macrovascular and microvascular complications in diabetes? The FACULTY protocol of a retrospective real-world cohort study
    Ramzi Ajjan, Tadej Battelino, Jochen Seufert, Patrick Blin, Gérard de Pouvourville, Éric Vicaut, Laure Carcaillon‐Bentata, Fleur Levrat‐Guillen, Emmanuel Cosson, Michaël Joubert · 2025 · BMJ Open
  17. Characterisation of transfusion-dependent prediabetes using continuous glucose monitoring: The Haemoglycare study
    Angela Zanfardino, Gülsüm Özen, Giorgia Ippolito, Domenico Roberti, Silverio Perrotta, Dario Iafusco, Emanuele Miraglia del Giudice, Maddalena Casale · 2025 · Diabetes Research and Clinical Practice
  18. Low-carbohydrate diet in type 1 diabetes: A systematic review
    Sabrina Soares de Santana Sousa, Erick Santos Nery, Fernando M. A. Giuffrida · 2025 · Clinical Nutrition ESPEN
  19. Diabetes risk assessment in adult population without diabetes employing continuous glucose monitoring: A novel approach
    Marcos Pazos-Couselo, Óscar Lado‐Baleato, Verónica Izquierdo, Jesús Moreno-Fernández, Manuela Alonso‐Sampedro, Carmen Fernández‐Merino, Francisco Gudé · 2025 · Diabetes Research and Clinical Practice
  20. Continuous Glucose Monitoring Systems Can Meet the Challenge of Glucose Management and Beyond in Individuals with Type 2 Diabetes: An Expert Multidisciplinary Position
    Małgorzata Myśliwiec, Leszek Czupryniak, Ryszard Gellert, Piotr Jankowski, Agnieszka Mastalerz–Migas, Marek Rękas, Krzysztof Strojek, Mieczysław Walczak · 2025 · Diabetes Therapy
  21. Measuring Hypothyroidism Disease Control Using a TSH-based “Time-in-range”
    Matthew David Ettleson, Nikita Thomas, Marcelo Ramírez, Wen Wan, Donald Hedeker, Antonio Carlos Bianco, Neda Laiteerapong · 2025 · The Journal of Clinical Endocrinology & Metabolism
  22. Hybrid Closed-Loop Insulin Delivery Systems for People With Type 1 Diabetes
    CADTH Health Technology Assessment Service · 2021 · Canadian Journal of Health Technologies
  23. Variation of glucose time in range in type 1 diabetes
    Klavs Würgler Hansen, Bo Martin Bibby · 2022 · Endocrinology Diabetes & Metabolism
  24. Across and Within- Individual Associations Between Everyday Activities and Quality of Life Relevant Measures, in Workers with Type 1 Diabetes
    Raymond Hernandez, Stefan Schneider, Loree T. Pham, Elizabeth Ann Pyatak · 2023 · Applied Research in Quality of Life
  25. Association of cumulative blood glucose load with cardiovascular risk and all-cause mortality
    Xue Tian, Shuohua Chen, Yijun Zhang, Xiaoli Zhang, Qin Hua Xu, Xue Xia, Penglian Wang, Yanxia Luo, Shouling Wu, Anxin Wang · 2023 · Diabetes & Metabolic Syndrome Clinical Research & Reviews
  26. Factors affecting the prolongation of glycemic time in range among children with type 1 diabetes using continuous glucose monitoring systems: A case control study
    Emilia Kowalczyk, Agnieszka Szypowska · 2024 · International Journal of Diabetes in Developing Countries
  27. Time‐in‐range derived from self‐measured blood glucose in people with type 2 diabetes advancing to iGlarLixi : A participant‐level pooled analysis of three phase 3 LixiLan randomized controlled trials
    Martin Haluzı́k, Mohammed E. Al‐Sofiani, ALICE Y.Y. CHENG, Felipe Lauand, Lydie Melas‐Melt, Julio Rosenstock · 2024 · Diabetes Obesity and Metabolism
  28. Effect of Imeglimin, a Novel Anti-Diabetic Agent, on Insulin Secretion and Glycemic Variability in Type 2 Diabetes Treated with DPP-4 Inhibitor: A 16-Week, Open Label, Pilot Study
    Atsushi Itsukaichi, Fukumi Yoshikawa, Ayako Fuchigami, Yoko Iwata, Genki Sato, Masahiko Miyagi, Takahisa Hirose, Hiroshi Uchino · 2025 · Diabetes Metabolic Syndrome and Obesity
  29. Pediatric type 1 diabetes
    Holly K. O’Donnell, Kimberly A. Driscoll · 2020 · Elsevier eBooks
  30. Evaluation of Hemoglobin A1c before and after initiation of continuous glucose monitoring in children with type 1 diabetes mellitus
    Shilpa Gurnurkar, Lindsey L Owens, Sweta Chalise, NEHA V. VYAS · 2021 · Journal of Pediatric Endocrinology and Metabolism
  31. The Use of Standardized Reporting and Time-in-Range in the Management of Diabetes: A Consensus Report
    Saud Al Sifri, Adnan Alshaikh, Bassam Saleh Bin-Abbas, Eman Sheshah, Fahad S. Al Sabaan, Mohammed Aldawish, Mohammed Al-Dubayee, Naweed SyedKhaleel Alzaman, Raed Aldahash, SAAD H. ALZAHRANI et al. · 2021 · International Journal of Clinical Medicine
  32. Distributional data analysis with accelerometer data in a NHANES database with nonparametric survey regression models
    Marcos Matabuena, Alex Petersen · 2021 · arXiv (Cornell University)
  33. Response to Comment on Lachin et al. Association of Estimated Time-in-Range Capillary Glucose Levels Versus HbA1c With Progression of Microvascular Complications in the Diabetes Control and Complications Trial. Diabetes Care 2022;45:2445–2448
    John M. Lachin, Ionut Bebu, Xiaoyu Gao, David M. Nathan, Bernard Zinman · 2022 · Diabetes Care
  34. Diabetic Nephropathy
    Peter R Rossing, Allan Flyvbjerg · 2024 · Wiley eBooks
  35. Association Between Time-in-Range and Diabetic Retinopathy: Learnings from DCCT to Recent Times
    Viral N. Shah, Lauren G. Kanapka, Roy W. Beck, Boris P. Kovatchev · 2025 · Diabetes Technology & Therapeutics
  36. Associations between time in range and insulin secretory capacity in Japanese patients with type 2 diabetes
    Kenichi Tanaka, Yosuke Okada, Fumi Uemura, Yoshiya Tanaka · 2024 · Scientific Reports
  37. A Pilot Study Examining If the Additional Use of a Continuous Glucose Monitoring Is Helpful for Glucose Control in Older Adults
    Kwang Joon Kim, Yang Sun Park, Eunseo Sun, Euna Jo, Jiwon Shinn, Hyeon Woo Yim, Chang Oh Kim, Hun‐Sung Kim · 2025 · Yonsei Medical Journal
  38. A CGM-Based model for predicting hypoglycemia in type 2 diabetes patients with TIR in target
    Jianwen Lu, Danrui Chen, Beisi Lin, Zhigu Liu, Yanling Yang, Ling He, Jinhua Yan, Daizhi Yang, Wen Xu · 2025 · Diabetology & Metabolic Syndrome
  39. Time in Tight Range in AHCL Systems: Propensity-Score-Matched Analysis of MiniMed 780G and Control-IQ
    M.S. Tapia Sanchiz, Víctor Navas-Moreno, Fernando Sebastián‐Valles, Juan José Raposo López, Carolina Sager La Ganga, Elena Carrillo-López, Sara González Castañar, Selma Amar, Marcos Lahera Vargas, José Alfonso Arranz Martín et al. · 2025 · Diabetology
  40. Association of the time in targeted blood glucose range of 140 to 180 mg/dL with the mortality of critically ill patients with diabetes: analysis of the MIMIC-IV database
    Huimin Ye, Zijian Ma, Qunchuan Zong, Qiang Zhu, Yufei Yan, Shengmei Yang, Pengyue Xiang, Huajie Zou · 2025 · Journal of Clinical & Translational Endocrinology
  41. Correlation between time in range and mild cognitive impairment in older adults with type 2 diabetes mellitus
    Jiajun Bao, Tianhong Xu, Ting Gu, Yi Xin Sun, Jiang Yilan, Jing Xiao, Yunjuan Gu · 2025 · Journal of Diabetes Investigation
  42. Once‐Weekly Insulin Efsitora Alfa Versus Once Daily Insulin in Patients With Type 2 Diabetes: A Systematic Review and Meta‐Analysis
    Harris Mehmood, Moaz Alowami, Thel Su Hlaing, Khant Nyi Zaya, Yousrah Uraiby, Ahmed Muaaz Alam, Abubakr Adala, Osama Ikram, Syed F. Ali, Muzammil Farhan et al. · 2025 · Endocrinology Diabetes & Metabolism
  43. Continuous glucose monitoring in high-risk individuals
    Zhiyue Chen, Yinbei Zhang, Lin Sun, Weiying Guo · 2025 · Clinica Chimica Acta
  44. Longitudinal study of arterial stiffness in pediatric patients with Type 1 Diabetes Mellitus (T1DM). Correlations with glycemic metrics derived from Continuous Glucose Monitoring (CGM) devices
    Eirini Georeli, Georgia Sotiriou, Athanasia Chainoglou, Assimina Galli‐Τsinopoulou, Stella Stabouli, Athanasios Christoforidis · 2026 · Diabetes Research and Clinical Practice
  45. Flash Continuous Glucose Monitoring: A Practical Guide and Call to Action for Pharmacists
    Kevin Cowart, Janice C. Zgibor · 2021 · Journal of Pharmacy Practice
  46. AGP und Ernährung – Mit CGM postprandiale Glukoseverläufe analysieren
    Jens Kroeger, Thorsten Siegmund, Oliver Schubert, Winfried Keuthage, Melanie Lettmann, Katja Richert, Andreas F. H. Pfeiffer · 2021 · Diabetologie und Stoffwechsel
  47. Spanish Consensus on the Use of Intermittently Scanned Continuous Glucose Monitoring in the Management of Patients With Insulin Therapy: The MONITOR Project
    Francisco Javier Ampudia‐Blasco, Estibaliz Ugarte, Ana Isabel Chico, Jorge Garcı́a-Alemán, Manuel Galan-Barroso · 2022 · Journal of Diabetes Science and Technology
  48. Comparison of continuous subcutaneous insulin infusion treatment and multiple daily injection treatment on the progression of diabetic complications in Japanese patients with juvenile‐onset type 1 diabetes mellitus
    Takafumi Masuda, Naoto Katakami, Naohiro Taya, Kazuyuki Miyashita, Mitsuyoshi Takahara, Ken Kato, Akio Kuroda, Munehide Matsuhisa, Iichiro Shimomura · 2022 · Journal of Diabetes Investigation
  49. Effectiveness of video consultations in type 1 diabetes patients treated with insulin pumps in the outpatient clinic: protocol for a randomised controlled trial
    A. N. Ø. Schultz, R. Christensen, G. Bollig, K. Kidholm, F. Brandt · 2022 · BMJ Open
  50. Application of glycemic qualification rate based on fingerstick glucose monitoring in women with gestational diabetes mellitus
    Rui Zeng, Xiaopei Cao, Nan Chen, Ling Pei, Changliu Xu, Chenxue Wang, Huiling Liu, Wanping Deng, Yanbing Li · 2023 · The Journal of Maternal-Fetal & Neonatal Medicine
  51. Mealtime Insulin BOLUS Score More Strongly Predicts HbA1c Than the Self-Care Inventory in Youth With Type 1 Diabetes
    Jordan Christie, Mark Allen Clements, David D. Williams, Joseph T. Cernich, Susana R. Patton · 2023 · Journal of Diabetes Science and Technology
  52. Fasting and postprandial plasma glucose contributions to hemoglobin A1c and time in range in people with diabetes on multiple daily injection insulin therapy: Results from the PRONTO-T1D and PRONTO-T2D clinical trials
    Carolina Piras de Oliveira, Mary Anne Dellva, Juliana M. Bue‐Valleskey, Annette M. Chang, Birong Liao · 2023 · Journal of Diabetes and its Complications
  53. Comparative effects of fixed‐dose mitiglinide/voglibose combination and glimepiride on vascular endothelial function and glycemic variability in patients with type 2 diabetes: A randomized controlled trial
    Kenichi Tanaka, Yosuke Okada, Saeko Umezu, Ryoma Hashimoto, Yukiko Tomoyose, Rina Tateyama, Yuri Hori, Momo Saito, Akemi Tokutsu, Satomi Sonoda et al. · 2023 · Journal of Diabetes Investigation
  54. Continuous and Intermittent Glucose Monitoring in 2023
    Klemen Dovč, Bruce W. Bode, Tadej Battelino · 2024 · Diabetes Technology & Therapeutics
  55. A sensor-augmented pump with a predictive low-glucose suspend system could lead to an optimal time in target range during pregnancy in Japanese women with type 1 diabetes
    Rie Kaneshima Tamura, Noriko Kodani, Arata Itoh, Shu Meguro, Hiroshi Kajio, Hiroshi Itoh · 2024 · Diabetology International
  56. The Relationship Between Hemoglobin A1c, Time in Range, and Glycemic Management Indicator in Patients With Type 1 and Type 2 Diabetes in a Tertiary Care Hospital in Saudi Arabia
    Ahmed A Alazmi, Imad Addin Brema, SAAD H. ALZAHRANI, Mohammed S. Almehthel · 2024 · Cureus
  57. Single-arm, first-in-human feasibility study results for an ultra-low-cost insulin pump
    Matthew Payne, Francis Pooke, Tom M. Wilkinson, Lui Rivers Holder-Pearson, Bronté Chamberlain, Martin I. de Bock, J. Geoffrey Chase · 2024 · BMC Endocrine Disorders
  58. Association of Continuous Glucose Monitoring–Derived Glycemia Risk Index With Cardiovascular Autonomic Neuropathy in Patients With Type 1 Diabetes Mellitus: A Cross-sectional Study
    Ji Eun Jun, You‐Bin Lee, Jae Hyeon Kim · 2024 · Journal of Diabetes Science and Technology
  59. Effectiveness and safety of iGlarLixi in people with type 2 diabetes not at target on basal insulin and oral antidiabetic therapy in a prospective observational trial
    Jochen Seufert, Tobias Wiesner, Katrin Pegelow, Julia Kenzler, Martin Pfohl · 2025 · Diabetes Obesity and Metabolism
  60. Impact of baseline alanine aminotransferase levels on the efficacy of dapagliflozin and sitagliptin: Latent class analysis from the DIVERSITY ‐ CVR study
    Kohei Mochizuki, Ayako Fuchigami, Takahisa Hirose, Hiroshi Uchino · 2025 · Diabetes Obesity and Metabolism
  61. Closed-loop insulin delivery system enhances type 1 diabetes glycemic control
    Julia Fuchs, Roman Hovorka · 2020 · The Journal of Pediatrics
  62. Показники контролю рівня глікемії: сучасний стан питання
    A.R. Kondratyshyn, M.S. Fik, У. О. Наумова, Liudmyla Valeriivna Naumova · 2022 · Endokrynologia
  63. Answering clinically pertinent questions with real-world data from paediatric type 1 diabetes registries
    Alfonso Galderisi, Jennifer L. Sherr · 2023 · The Lancet Diabetes & Endocrinology
  64. Advances in Pharmacotherapeutics, Metabolic Surgery, and Technology for Diabetes
    Alfredo Daniel Guerron, Georgia M. Davis, Francisco J. Pasquel · 2021 · Endocrinology and Metabolism Clinics of North America
  65. Time in range, as an emerging metric of glycemic control, is associated with orthostatic blood pressure changes in type 2 diabetes
    Yanyu Yuan, Bin Lü, Qingyu Guo, Wei Wang, Zhouqin Feng, Xuguang Jin, Hui Zhou, Jun Liu, Haiyan Lei, Xinyi Yang et al. · 2021 · Diabetes Research and Clinical Practice
  66. Efficacy of Russian insulin biosimilars for type 1 diabetes in adolescents
    Платонов Вадим Валерьевич, Дубинина Татьяна Александровна, Evgenia Mikhailovna Patrakeeva, A.M. Rezvykh, N.V. Kazachenko Kazachenko · 2022 · Russian Journal of Woman and Child Health
  67. Time-in-range: a promising glycemic control metric for bariatric surgery
    Meng Kang, Weizheng Li · 2022 · Surgery for Obesity and Related Diseases
  68. Time in range is associated with less hypoglycemia fear and higher diabetes technology acceptance in adults with well-controlled T1D
    Setareh Aslani, Claudia Westergaard Jensen, Annika Oddmarsdóttir Olsson, Sofie Secher Thomsen, Simon Lebech Cichosz · 2022 · Journal of Diabetes and its Complications
  69. Diabetes mellitus im Kindes- und Jugendalter (Update 2023)
    Birgit M. Rami-Merhar, Elke Elisabeth Fröhlich-Reiterer, Sabine E. Hofer, Maria Fritsch · 2023 · Wiener klinische Wochenschrift
  70. The Relationship Between Glycated Hemoglobin and Time in Range in a Pediatric Population
    Mathilde Vandenbempt, Hanne Matheussen, Sara Charleer, Anne Maria Rochtus, Kristina Casteels · 2023 · Diabetes Technology & Therapeutics
  71. Analysis of time in range depending on the method of assessing the glucose level
    Л. А. Суплотова, Судницына Анна Сергеевна, Н. В. Романова, K. A. Sidorenko, Л.Ю. Радионова, T. V. Gracheva, Н. В. Плотников, E. V. Khieva, Olesia Yu. Shabelnikova, Irina Ipatko et al. · 2021 · Meditsinskiy sovet = Medical Council
  72. Initial Diagnosis and Management of Type 2 Diabetes Mellitus
    Nisha Suda, Hanna J. Lee · 2022 · Springer eBooks
  73. Psychosocial Assessment Tools for Youth with Type 1 Diabetes: a 10-Year Review
    Trevor Bell, Elizabeth Hazel · 2022 · Current Diabetes Reports
  74. Controle glicêmico de pessoas com diabetes mellitus na atenção primária à saúde em Ribeirão Preto
    Adrielen Aparecida Silva Calixto · 2020 · Digital Library of Theses and Dissertations (Universidade de São Paulo)
  75. Beyond Mean Absolute Relative Difference (MARD): Rethinking Continuous Glucose Monitoring (CGM) Evaluation for Real-World Diabetes Care
    Matteo Acanfora, Erika Pedone, Barbara Presciuttini, Francesca Ré, Luca Acanfora · 2025 · Cureus
  76. Professional flash glucose monitoring and health service utilisation in type 2 diabetes: A secondary analysis of the GP-OSMOTIC study
    Rita McMorrow, Sharmala Thuraisingam, John Furler, Jo-Anne Elizabeth Manski-Nankervis · 2020 · Primary care diabetes
  77. Diabetes Technology and Therapy in the Pediatric Age Group
    David M. Maahs, Priya Prahalad, Darja Šmigoc Schweiger, Shlomit Shalitin · 2023 · Diabetes Technology & Therapeutics
  78. Trends in Time in Range–Related Publications and Clinical Trials: A Bibliometric Review
    Pranav M. Patel, Richard M. Abaniel, Natasha Dogra, Charles B. Lo, Marie A. Frazzitta, Naunihal S. Virdi · 2023 · Diabetes Spectrum
  79. Correlation between time in range and serum uric acid in Chinese patients with type-2 diabetes: an observational cross-sectional study
    Yan Liu, Xiaoren Peng, Chunjian Qiu, Jiaqing Shao · 2024 · Diabetology & Metabolic Syndrome
  80. A Minimal Model for Type-1 DM Patients: Meal and Exercise Adaptation
    Abishek Chandrasekhar, Radhakant Padhi · 2024 · IFAC-PapersOnLine
  81. Using Ecological Momentary Assessment (EMA) to understand occupation from the perspective of the experiencing self: An illustrative example in workers with type 1 diabetes
    Raymond Hernandez, Rebecca M. Aldrich, Stefan Schneider, Arthur A. Stone, Shawn C. Roll, Elizabeth Ann Pyatak · 2024 · Journal of Occupational Science
  82. Can 4 weeks of real-world active breaks improve glycaemic management in sedentary adults with type 1 diabetes? The EXTOD-Active randomised control trial protocol
    Joseph G Jenkins, Matthew S. Cocks, Parth Narendran, Robert Charles Andrews, Beverley M. Shields, Sam N. Scott, Samuel J. E. Lucas, Catarina Rendeiro, Katie Louise Hesketh · 2025 · BMJ Open Sport & Exercise Medicine
  83. Exogenous vs Endogenous Insulin Delivery: 2025
    Ankit Patel, Rachel Todd, N. Owen-Simon, K. McCune · 2025 · Current Transplantation Reports
  84. Once-weekly insulin icodec vs. daily insulin glargine in type 2 diabetes: a meta-analysis with longitudinal insights
    Taimoor Ashraf, Akshy Kumar, Aniket Tara, Naila Memon, Areej Muhammad, Muskan Turesh, Shah Dev, Noor Muhammad, Vikash Kumar, Tooba Hussain et al. · 2025 · Annals of Medicine and Surgery
  85. A Digital Diabetes Self-Management Education and Support Program Integrated With Continuous Glucose Monitoring for Type 2 Diabetes: Randomized Controlled Trial
    Ashley Berthoumieux, Jeanean B. Naqvi, Sean R. Zion, Jenna M. Napoleone, Amanda McGuill, Christian Jules Cerrada, Hyun Jung Lee, Timothy C. Dunn, David E. Kerr, Carolyn Bradner Jasik et al. · 2026 · Journal of Medical Internet Research
  86. Effective blood glucose control in Chinese children with type 1 diabetes via a do-it-yourself artificial pancreas system: a single-center study
    Lihong Yang, Fei Xie, Linqi Han, Fengyan You, Zhiqiang Wei, Caihong Liu, Chao Xu, Yakai Sun · 2025 · Therapeutic Advances in Endocrinology and Metabolism
  87. Impaired central thyroid hormone sensitivity is associated with time in range in patients with type 2 diabetes mellitus in the euthyroid population
    Jiang Xu, Yu Gong, Guojuan Wang, Ying Li · 2025 · Diabetology & Metabolic Syndrome
  88. Implementation of a continuous glucose monitoring workflow in a complex primary care clinic
    Jack Weisskohl, Dana Burns, Evan M. Sisson, Kathryn Reid · 2025 · Journal of the American Association of Nurse Practitioners
  89. The Impact of Two Different Insulin Dose Calculation Methods on Postprandial Glycemia After a Mixed Meal in Children with Type 1 Diabetes: A Randomized Study
    Magdalena Dymińska, Emilia Kowalczyk, Katarzyna Piechowiak, Agnieszka Szypowska · 2025 · Nutrients
  90. Association between carbohydrate quality and glycemic control in individuals with type 1 diabetes: A cross-sectional and meal-based analysis
    Lingling Bian, Chun Yang, Yanjun Jin, Hong Wang, Min Zhu, Jingjing Xu, Jianling Bai, Mei Zhang, Yanmei Liu, Tao Yang et al. · 2026 · PLoS ONE
  91. Impact of continuous glucose monitoring on glycaemic risk index in adults with type 1 diabetes using multiple daily insulin injections in the GOLD trial
    Daniel Pylov, Sofia Sterner Isaksson, Henrik Imberg, David Charles Klonoff, Marcus Lind · 2026 · Frontiers in Clinical Diabetes and Healthcare
  92. Gymnema sylvestre-supplemented chewing gum and sweet food consumption in type 1 diabetes: a randomized, double-blind pilot trial (the sweet victory trial)
    Assaf Buch, Jacob Atsmon, Michal Roll, Gitit Lahav, Shimrit Lev, Roy Eldor · 2026 · Diabetes Epidemiology and Management
  93. Association between continuous glucose monitoring metrics and diabetic retinopathy and albuminuria among Japanese individuals with type 1 diabetes
    Yuichiro Kondo, Ryo Kubota, Rika Suda, Yukiko Hasegawa, Junko Oya, Satoshi Takagi, Hiroko Takaike, Junnosuke Miura, Tomoko Nakagami · 2026 · Journal of Diabetes Investigation
  94. Personalized Forecasting of Glycemic Control in Type 1 and 2 Diabetes Using Foundational AI and Machine Learning Models
    Simon Lebech Cichosz, Stine Hangaard, Thomas Kronborg, Peter Vestergaard, Morten Hasselstrøm Jensen · 2026 · Diabetes Technology and Obesity Medicine
  95. Effects of time-restricted eating on glycemic control and variability in individuals with overweight/obesity and prediabetes: A secondary analysis of the RESET randomized controlled trial
    Christina Kloura, Marie Møller Jensen, Trine Spragge Ekblond, Hanne Pedersen, Anne Raben, Kim Katrine Bjerring Clemmensen, Kristine Færch, Martin Bæk Blond, Jonas Salling Quist · 2026 · Diabetes Research and Clinical Practice
  96. Virtual Weight Management and Continuous Glucose Monitoring in Patients With Type 2 Diabetes: A Randomized Controlled Trial
    Peter Todd Katzmarzyk, KIMBERLY DREWS, Jamy D. Ard, Tracey McLaughlin, Melissa N. Harris, Alexandra Lee, Gary D. Foster, Hyun Jung Lee, Timothy C. Dunn, Corby K. Martin et al. · 2026 · Obesity
  97. Interpreting Continuous Glucose Monitoring Through Metabolic Physiology: A Framework for Precision Nutrition in Type 2 Diabetes
    Jitendra D. Belani · 2026 · Nutrients
  98. Lack of association between Triglyceride glucose-body mass index and glomerular filtration rate in patients with coronary heart disease after percutaneous coronary intervention: a retrospective case-control study
    Xiaoxu Zhang, Zihe Zhang, Xiaoxiao Yu, Xiaoyuan Zhang, Haoyang Liu, Yi'na Le, Shan Wang, Feng Gao, Feng Yang, Jiahui Chen · 2026 · Frontiers in Endocrinology
  99. Association between worsening time in range and microvascular complications in type 1 diabetes: real-world 5-year study
    Amber C.F. Sabbe, Niels Bochanen, Annelies Van den Broucke, Katarina Mihaljčić, Axelle Bigaré, Kristof Van Dessel, Jason Bouziotis, Kristien J. Ledeganck, Eveline Lia Dirinck, Nancy Bolsens et al. · 2026 · The Journal of Clinical Endocrinology & Metabolism
  100. Progression of Diabetic Complications in Subgroups of People with Long Term Diabetes Type 1 According to Clinical Course
    Christian Gerdes, Christoph Werner, Christof Kloos, Thomas Lehmann, Günter Wolf, Ulrich Müller, Nicolle Muller · 2020 · Experimental and Clinical Endocrinology & Diabetes